Results 161 to 170 of about 109,974 (359)

Hypertension and its complications in a young man with autoimmune disease [PDF]

open access: yes, 2017
Basile, Jan N.   +9 more
core   +1 more source

A METHOD ON EVALUATION OF ANTIHYPERTENSIVE AGENT BY EXPERIMENTAL ANIMAL

open access: gold, 1973
Riichiro Iwaki   +6 more
openalex   +1 more source

Antiobesity Medications for Older Adults—the New, the Good, the Bad, and the Unknown

open access: yesObesity, EarlyView.
ABSTRACT Objective Obesity affects 42% of older adults, with rates continuing to rise. This a complex condition influenced by non‐modifiable as well as modifiable risk factors. The disease can be treated through modifications to diet, physical activity, and behavior and more recently through antiobesity medications (AOMs) and surgery. Treatment must be
Anna Pendrey, Javier Sevilla‐Martir
wiley   +1 more source

Preoperative Care Clinic Improves Survival for Patients Undergoing Free‐Flap Reconstruction

open access: yesOtolaryngology–Head and Neck Surgery, EarlyView.
Abstract Objective This study aims to evaluate whether perioperative care improves postoperative outcomes for head and neck reconstruction patients with preexisting health conditions. Study Design Retrospective cohort study. Setting Single tertiary academic center between 2013 and 2021. Methods This study included adult patients who underwent free‐flap
Randall J. Harley   +8 more
wiley   +1 more source

Angiotensin II Receptor Blockers (ARBs Antihypertensive Agents) Increase Replication of SARS-CoV-2 in Vero E6 Cells. [PDF]

open access: yesFront Cell Infect Microbiol, 2021
Pires de Souza GA   +6 more
europepmc   +1 more source

Long‐term remission in gout: Challenges and future opportunities

open access: yesRheumatology &Autoimmunity, EarlyView.
Prolonged hyperuricemia is a major risk factor for gout, which is now regarded as a curable disease. Awareness of the various factors that can trigger gout flares is essential for their prevention. An important determinant of treatment decisions and long‐term follow‐up is the quality of the clinician–patient relationship. The “treat‐to‐target” approach
Patapong Towiwat, Zhanguo Li
wiley   +1 more source

Home - About - Disclaimer - Privacy